ACE2 and COVID-19: The neuroinvasive potential of the SARS-CoV-2 virus explaining the presence of neuropathic pain symptoms in COVID-19 survivors can be explained by the high expression of angiotensin converting enzyme-2 (ACE2) receptors detected within nervous system cells including neurons and microglia in the spinal dorsal horn [20].